Corteva's genetically modified Enlist platform has had wins over Bayer in recent years in gaining approval for its GMO seeds to be imported into China, which should boost Enlist's market share.

Third Point posted a gain in October and is now up more than 18 percent for the year, according to the firm’s monthly report ...

With climbing biotech M&A and IPO activity following the post-pandemic slump, experts offer insights on maximizing value and ...

Mizuho Securities analyst John Roberts CFA has maintained their bullish stance on DD stock, giving a Buy rating on October 24. John Roberts ...

Barclays analyst Michael Leithead raised the firm’s price target on DuPont (DD) to $85 from $84 and keeps an Underweight rating on the ...

S&P Dow Jones Indices will replace chemical and plastics maker Dow Inc. on the Dow Jones Industrial Average list with Sherwin ...

In a tough fundraising space, cell therapy biotechs pursuing autoimmune indications review staffing to ensure the right ...

A 79-year-old man who was killed after he rode his electric bike into the path of a pickup truck Saturday has been identified by police as William Blatt. Delaware State Police said part of their ...

Stocks were rising Tuesday as voters headed to the polls to elect the next U.S. president.These stocks were making moves ...

These products are used in the company’s specialized end products or sold externally. Celanese produces these commodity chemicals in its acetyl chain segment (roughly 53% of 2023 operating EBITDA), ...

DuPont de Nemours raised its full-year profit forecast after topping third-quarter estimates on Tuesday, as the industrial ...

DuPont de Nemours has a better P/E ratio of 104.94 than the aggregate P/E ratio of 47.08 of the Chemicals industry. Ideally, ...